STOCK TITAN

HealthEquity (HQY) CEO Cutler Scott uses 1,238 shares for tax withholding

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HEALTHEQUITY, INC. director and President and CEO Cutler Scott reported a Form 4 transaction for Common Stock. On July 8, 2026, 1,238 shares were disposed of as a tax-withholding disposition at an effective price of $95.0831 per share to satisfy tax obligations. Following this withholding, Cutler Scott directly holds 176,405 shares of common stock.

Positive

  • None.

Negative

  • None.
Insider Cutler Scott
Role President and CEO
Type Security Shares Price Value
Tax Withholding Common Stock 1,238 $95.0831 $118K
Holdings After Transaction: Common Stock — 176,405 shares (Direct, null)
Footnotes (1)
Tax-withholding shares disposed 1,238 shares Common Stock disposed on July 8, 2026 as a tax-withholding disposition
Effective price per share $95.0831 per share Value used for the 1,238-share tax-withholding disposition
Shares held after transaction 176,405 shares Direct ownership of common stock following the July 8, 2026 disposition
tax-withholding disposition financial
"transaction_action: tax-withholding disposition"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Payment of exercise price or tax liability by delivering securities financial
"transaction_code_description: Payment of exercise price or tax liability"
Form 4 financial
"reported a Form 4 transaction for Common Stock"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did HEALTHEQUITY (HQY) CEO Cutler Scott report on this Form 4?

Cutler Scott reported a tax-withholding disposition of HEALTHEQUITY common stock. The transaction used existing shares to satisfy tax liabilities, rather than an open-market sale or purchase, and was reported as a Form 4 insider transaction.

How many HEALTHEQUITY (HQY) shares were used for tax withholding?

A total of 1,238 shares of HEALTHEQUITY common stock were disposed of as a tax-withholding transaction. This means the shares were delivered to cover tax obligations instead of being sold in the open market.

At what price were the HEALTHEQUITY (HQY) shares valued for the tax-withholding disposition?

The 1,238 shares were valued at $95.0831 per share for the tax-withholding disposition. This effective price is used to calculate the value of shares delivered to satisfy the President and CEO’s tax liability.

How many HEALTHEQUITY (HQY) shares does Cutler Scott hold after this Form 4 transaction?

After the tax-withholding disposition, Cutler Scott directly holds 176,405 shares of HEALTHEQUITY common stock. This figure reflects his direct ownership position immediately following the reported July 8, 2026 transaction.

Was the HEALTHEQUITY (HQY) Form 4 transaction an open-market sale or purchase?

No. The transaction is classified as a tax-withholding disposition, not an open-market buy or sell. Shares were delivered to pay tax liabilities, and the Form 4 does not report any open-market trading activity.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cutler Scott

(Last)(First)(Middle)
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100

(Street)
DRAPER UTAH 84020

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/08/2026F1,238D$95.0831176,405D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
The Power of Attorney given by Mr. Cutler was previously filed with the U.S. Securities and Exchange Commission on January 10, 2025 as an exhibit to a statement on Form 3 filed by Mr. Cutler with respect to HealthEquity, Inc. and is hereby incorporated by reference.
/s/ Michael Newton, Attorney-in-Fact07/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)